Lymphoscintigraphy & Sentinel Node Mapping⁹⁹ᵐTc-sulfur colloid / ⁹⁹ᵐTc-tilmanocept

Quick Answer

Lymphoscintigraphy maps lymphatic drainage from a tumor to its sentinel lymph node(s) — the first node(s) draining the site — so the surgeon can selectively biopsy them. A radiocolloid (Tc-99m-sulfur colloid or the receptor-targeted Tc-99m-tilmanocept) is injected around the primary/biopsy site; imaging (± SPECT/CT) and an intraoperative gamma probe (often with blue dye) localize the node. It is standard in melanoma and breast cancer nodal staging and spares many patients a full nodal dissection.

Principle & technique

• Injection: intradermal/peritumoral radiocolloid; smaller particles migrate faster (tilmanocept binds nodal mannose receptors, giving high node retention and low distal spread).
• Imaging: dynamic/static planar to track drainage basins; SPECT/CT localizes nodes anatomically (especially head/neck, pelvis, aberrant drainage).
• Intraoperative: gamma probe ± vital blue dye identifies the hottest/blue node(s).

Evidence

• Melanoma: sentinel node status is the strongest prognostic factor; the MSLT trials defined the role of sentinel biopsy and the (limited) value of completion dissection.
• Breast: sentinel node biopsy is accurate and, when negative, avoids axillary dissection (NSABP B-32 and subsequent trials).

Map the first-draining node, spare the dissection

Lymphoscintigraphy maps drainage from a tumor to its sentinel node(s) — the first node(s) draining the site — so the surgeon selectively biopsies them: a negative sentinel node reliably spares a full nodal dissection. A radiocolloid (Tc-99m-sulfur colloid or receptor-targeted tilmanocept) is injected around the site; SPECT/CT localizes nodes anatomically (essential for head/neck, pelvis, aberrant drainage) and an intraoperative gamma probe ± blue dye finds them. It is standard nodal staging in melanoma (MSLT; sentinel status is the strongest prognostic factor) and breast cancer (NSABP B-32).

High-Yield Pearls

• SPECT/CT is especially valuable for head-and-neck and unexpected/aberrant drainage basins.
• A negative sentinel node reliably spares full nodal dissection in appropriate patients.
• Tilmanocept's receptor targeting improves sentinel-node retention and reduces confusing secondary nodes.

Common Pitfalls

• Missing aberrant or multiple drainage basins on planar imaging alone (use SPECT/CT).
• Injection-site "shine-through" obscuring an adjacent node.
• Very rapid or absent migration degrading localization.

Related Pages

• Diseases: Melanoma, Breast cancer; contrast: Lymphedema lymphoscintigraphy.

Self-Check